Close
Digital Health & Ai Innovation summit 2026
APE 2026

Toshiba introduced next generation CV-3D for infinix cardiovascular

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA May Scrutinize Medical Device Cybersecurity...

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare...

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

Toshiba America Medical Systems, Inc. has introduced its Next Generation CV-3D™ workstation and software package available on the Infinix™-i X-ray product line. Next Generation CV-3D is an integrated reconstruction workstation and software, designed to take a 2D X-ray image and reconstruct a new, more detailed 3D image in a matter of seconds.

 The new image provides a 3D reconstructed view of the same vessel under study, allowing physicians to determine the best treatment plan. CV-3D visualization assists physicians in selecting the most appropriate stent, potentially reducing the need for additional invasive devices. Some of the latest enhancements optimize stent selection and positioning by automatically including markers in the view and providing a clear view of the stent in relationship to the vessel wall, which validates proper stent deployment. Clinicians also can increase workflow by utilizing the Infinix-i tableside controls to display the preferred CV-3D image in the examination room.

Robert Micer, director, X-ray Vascular Business Unit, Toshiba said, This new workstation and software have the ability to improve patient safety and lower health care costs by eliminating additional invasive procedures and leading to more precise treatment plans.

Latest stories

Related stories

FDA May Scrutinize Medical Device Cybersecurity More in 2026

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare Receives a PMA

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »